Institutional investors now control 84.58 percent of the company's shares.
In the quiet arithmetic of institutional portfolios, Keysight Technologies has become a destination — a place where large pools of capital are choosing to gather. During the first quarter, the world's most deliberate money managers expanded their stakes in this scientific instruments company, drawn by earnings that exceeded expectations and revenue growth that confirmed the business is accelerating. The convergence of analyst upgrades, institutional accumulation, and operational momentum tells a familiar story in markets: confidence, once earned, tends to compound.
- GAMMA Investing's position exploded by more than 36,000 percent in a single quarter, a move so dramatic it signals either deep conviction or a near-complete repositioning into Keysight.
- Price T Rowe and Victory Capital — two of Wall Street's most measured institutions — added billions in exposure, suggesting this is not speculative enthusiasm but considered, long-horizon commitment.
- Keysight's August earnings report delivered the validation investors needed: $1.72 per share beat estimates, revenue surpassed forecasts by $30 million, and year-over-year growth hit 11.1 percent.
- Analyst upgrades cascaded from Morgan Stanley, JPMorgan, and Barclays, pushing price targets toward $200 and cementing a consensus moderate-buy rating with an average target of $187.38.
- Insider selling by two senior executives — modest in scale but notable in timing — introduces a quiet counterpoint to the institutional enthusiasm surrounding the stock.
- With shares trading at a P/E of nearly 54 times earnings and institutional ownership at 84.58 percent, the optimism appears largely priced in, leaving little margin for disappointment.
Keysight Technologies has become the subject of a notable reshuffling among Wall Street's largest money managers. Through the first quarter, most major institutional investors moved to increase their stakes in the scientific instruments company, reflecting growing confidence in a business consistently outperforming expectations.
The scale of some moves was striking. Price T Rowe Associates expanded its holding by 16.6 percent, adding nearly 2.7 million shares to reach a position worth $2.8 billion. Victory Capital Management increased its stake by more than 1,200 percent, while GAMMA Investing executed the most dramatic maneuver of all — growing its position by over 36,000 percent to end the quarter holding shares worth $112 million. Point72 and ANTIPODES PARTNERS also added substantially. Only Advisors Asset Management trimmed its exposure, selling just 821 shares. Institutional investors now control 84.58 percent of the company.
The buying reflects Keysight's operational strength. In August, the company reported second-quarter earnings of $1.72 per share, beating estimates by five cents, while revenue of $1.35 billion exceeded forecasts and grew 11.1 percent year over year. Net profit margin stands at 10.36 percent, and return on equity reached 19.53 percent.
Analysts have responded with upgrades and higher targets. Morgan Stanley, JPMorgan, and Barclays all assigned overweight ratings, with JPMorgan pushing its target to $200. The consensus now sits at a moderate buy with an average price target of $187.38.
Amid the enthusiasm, two senior insiders sold modest amounts of stock in June — a common occurrence at companies with strong momentum, though a quiet counterpoint to the institutional tide flowing in. Keysight's stock trades near $169, well above its 52-week low but below its high of $186.20, with a market capitalization of $29 billion and a P/E ratio of nearly 54 times earnings — a valuation suggesting much of the optimism has already been absorbed into the price.
Keysight Technologies has become the focus of a significant reshuffling among Wall Street's largest money managers. During the first quarter, most major institutional investors moved to increase their stakes in the scientific instruments company, even as one prominent firm trimmed its position. The moves reflect growing confidence in a business that has been delivering stronger results than Wall Street expected.
Price T Rowe Associates, one of the world's largest asset managers, expanded its Keysight holding by 16.6 percent in the quarter, adding nearly 2.7 million shares to bring its total to 18.8 million shares worth $2.8 billion. Victory Capital Management made an even more dramatic move, increasing its position by more than 1,200 percent—acquiring 1.8 million shares to reach a stake valued at $298 million. GAMMA Investing, a smaller player, executed the most eye-catching maneuver of all, growing its position by more than 36,000 percent in the quarter, ending with 750,647 shares worth $112 million. Point72 Asset Management and ANTIPODES PARTNERS also substantially increased their exposure. Only Advisors Asset Management trimmed its holdings, selling 821 shares to reduce its stake by 7.5 percent, leaving it with $1.5 million in Keysight stock. Institutional investors now control 84.58 percent of the company's shares.
The buying spree reflects confidence in Keysight's operational momentum. In August, the company reported second-quarter earnings of $1.72 per share, beating analyst expectations by five cents. Revenue reached $1.35 billion, exceeding forecasts by $30 million and growing 11.1 percent from the same quarter a year earlier. The company's net profit margin stands at 10.36 percent, and it generated a 19.53 percent return on equity. Management guided for full-year earnings between $7.09 and $7.09 per share, with fourth-quarter earnings expected to land between $1.79 and $1.85 per share.
Wall Street's analyst community has responded with a series of upgrades and higher price targets. Morgan Stanley raised its target from $156 to $180 in May, assigning an overweight rating. JPMorgan Chase pushed its target even higher, moving from $177 to $200 in July, also with an overweight stance. Barclays, while maintaining an overweight rating, modestly reduced its target from $200 to $195 in August. Bank of America lifted its target from $175 to $179, though it assigned a neutral rating. Wall Street Zen upgraded the stock from buy to strong buy. Seven analysts now rate the stock as a buy, with one holding at neutral, giving the company a consensus rating of moderate buy and an average price target of $187.38.
Insiders have been selling modest amounts of stock, a common occurrence at companies with strong momentum. In June, senior vice president Ingrid Estrada sold 10,000 shares at an average price of $158.97, reducing her stake by 8.43 percent but leaving her with 108,590 shares worth $17.3 million. Chief financial officer Neil Dougherty sold 12,215 shares on June 30 at $164.60 per share, trimming his position by 9.58 percent while retaining 115,228 shares valued at $19 million. Insiders collectively own just 0.61 percent of the company.
Keysight's stock opened Tuesday at $169.14, sitting between a 52-week low of $121.43 and a high of $186.20. The company carries a market capitalization of $29.07 billion and trades at a price-to-earnings multiple of 53.86 times, with a price-to-earnings-to-growth ratio of 2.35. Its balance sheet remains solid, with a current ratio of 3.59, a quick ratio of 2.94, and a debt-to-equity ratio of 0.45. The stock's 50-day moving average sits at $164.03, while its 200-day average is $156.85. The company operates in two segments—Communications Solutions Group and Electronic Industrial Solutions Group—serving industries ranging from aerospace and defense to semiconductors and automotive. With institutional money flowing in, analyst targets climbing, and earnings beating expectations, Keysight appears positioned for continued strength, though valuations at current levels suggest much of the optimism is already priced in.
Notable Quotes
The company reported earnings of $1.72 per share, beating consensus estimates by $0.05, with revenue of $1.35 billion exceeding forecasts.— Keysight Technologies Q2 2025 earnings report
Seven research analysts have rated the stock with a Buy rating and one has given a Hold rating, with a consensus rating of Moderate Buy.— Wall Street analyst consensus
The Hearth Conversation Another angle on the story
Why are so many major investors suddenly buying Keysight stock at the same time?
It's not really sudden—it's a response to consistent execution. The company beat earnings estimates, grew revenue double digits, and guided higher. When that happens, money managers who've been watching from the sidelines start moving in.
But GAMMA Investing's position grew by 36,000 percent. That's not normal buying. That's starting from almost nothing.
Right. GAMMA went from essentially zero to 750,000 shares. It's dramatic in percentage terms, but it's still a $112 million position—meaningful, but not enormous in the context of a $29 billion company. The bigger story is Price T Rowe, which already owned 16 million shares and added 2.7 million more. That's real institutional conviction.
The insiders are selling though. Doesn't that suggest they think the stock is overvalued?
Not necessarily. Executives sell for lots of reasons—diversification, tax planning, life events. These sales are small relative to their total holdings. Estrada still owns 108,000 shares after her sale. That's not someone bailing out.
What about the valuation? A P/E of 53 seems high.
It is high by historical standards, but it's not unusual for a company growing revenue at 11 percent with strong margins and a 19 percent return on equity. The market is pricing in continued growth. The question is whether Keysight can deliver it.
And can it?
The guidance suggests confidence. They're guiding for full-year earnings of $7.09 per share, and analysts on average expect $6.32. If management hits their numbers, the stock probably justifies the current price. If they miss, it gets ugly fast.